Docetaxel in the treatment of prostate cancer: Opportunities for combination regimens and challenges to development

被引：0
|
作者：
Logothetis, CJ [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [41] Different therapeutic regimens in the treatment of metastatic prostate cancer
    Huang, Shuai
    Huang, Sheng
    Pan, Jiangang
    Lin, Zhuoyuan
    Tang, Yubo
    Wa, Qingde
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (12) : 4361 - 4362
  • [42] Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment
    Lucs, Alexandra V.
    Saltman, Benjamin
    Chung, Christine H.
    Steinberg, Bettie M.
    Schwartz, David L.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (02): : 294 - 306
  • [43] Promising combination treatment for prostate cancer
    Nature Reviews Urology, 2015, 12 (6) : 302 - 302
  • [44] Practical issues facing urologists in the treatment of prostate cancer: Opportunities and challenges with the current standard of care
    Crawford, ED
    UROLOGY, 2003, 62 (6A) : 1 - 2
  • [45] Challenges and Opportunities for Childhood Cancer Drug Development
    Houghton, Peter J.
    Kurmasheva, Raushan T.
    PHARMACOLOGICAL REVIEWS, 2019, 71 (04) : 671 - 697
  • [46] Challenges and opportunities in childhood cancer drug development
    Robin E. Norris
    Peter C. Adamson
    Nature Reviews Cancer, 2012, 12 : 776 - 782
  • [47] Challenges and opportunities in childhood cancer drug development
    Norris, Robin E.
    Adamson, Peter C.
    NATURE REVIEWS CANCER, 2012, 12 (11) : 776 - 782
  • [48] Future opportunities for the diagnosis and treatment of prostate cancer
    R W G Watson
    J A Schalken
    Prostate Cancer and Prostatic Diseases, 2004, 7 : S8 - S13
  • [49] Future opportunities for the diagnosis and treatment of prostate cancer
    Watson, RWG
    Schalken, JA
    PROSTATE CANCER AND PROSTATIC DISEASES, 2004, 7 (Suppl 1) : S8 - S13
  • [50] Use of docetaxel in combination with octreotide as a synergistic combination for prostate cancer with apoptotic and antiangiogenic effects.
    Karaca, Burcak
    Atmaca, Harika
    Bozkurt, Emir
    Sezgin, Canfeza
    Karabulut, Buient
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345